| 2021-03-10 | Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages | Je, Hyeonwoo; Nam, Gi-Hoon; Kim, Gi Beom; Kim, Wonjun; Kim, Soo Rin; Kim, In-San; Lee, Eun Jung |
| 2021-03-10 | The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy | Kwon, Minsu; Jung, Hanul; Nam, Gi-Hoon; Kim, In-San |
| 2021-07 | Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer | Nam, Gi-Hoon; Kwon, Minsu; Jung, Hanul; Ko, Eunbyeol; Kim, Seong A.; Choi, Yoonjeong; Song, Su Jeong; Kim, Seohyun; Lee, Yeji; Kim, Gi Beom; Han, Jihoon; Woo, Jiwan; Cho, Yakdol; Jeong, Cherlhyun; Park, Seung-Yoon; Roberts, Thomas M.; Cho, Yong Beom; Kim, In-San |
| 2021-12-01 | Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma | Kwon, Minsu; Nam, Gi-Hoon; Jung, Hanul; Kim, Seong A.; Kim, Seohyun; Choi, Yeonju; Lee, Yoon Se; Cho, Hyo Jung; Kim, In-San |
| 2021-08 | Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia | Choi, Jeong Uk; Lee, Na Kyeong; Seo, Hyungseok; Chung, Seung Woo; Al-Hilal, Taslim A.; Park, Seong Jin; Kweon, Seho; Min, Nuri; Kim, Sang Kyoon; Ahn, Seohyun; Kim, Uk-Il; Park, Jin Woo; Kang, Chang-Yuil; Kim, In-San; Kim, Sang Yoon; Kim, Kyungjin; Byun, Youngro |
| 2021-05-10 | Design of PD-1-decorated nanocages targeting tumor-draining lymph node for promoting T cell activation | Kim, Gi Beom; Sung, Hyo-Dong; Nam, Gi-Hoon; Kim, Wonjun; Kim, Seohyun; Kang, Dayeon; Lee, Eun Jung; Kim, In-San |
| 2021-08 | Oral Cancer Immunotherapy through a Simvastatin-Loaded Colloidal Dispersion System for the Generation of Sustained Antitumor Immunity | Kim, Seong A.; Nam, Gi-hoon; Bae, Young Rang; Jha, Saurav Kumar; Kim, Seohyun; Choi, Yoonjeong; Lee, Yeji; Kwon, Minsu; Jeong, Cheolhyun; Byun, Youngro; Park, Jin Woo; Kim, In-San |
| 2021-12 | Rho-Kinase as a Target for Cancer Therapy and Its Immunotherapeutic Potential | Kim, Seohyun; Kim, Seong A.; Han, Jihoon; Kim, In-San |
| 2021-05 | Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity | Yang, Suah; Shim, Man Kyu; Kim, Woo Jun; Choi, Jiwoong; Nam, Gi-Hoon; Kim, Jeongrae; Kim, Jinseong; Moon, Yujeong; Kim, Han Young; Park, Jooho; Park, Yoon; Kim, In-San; Ryu, Ju Hee; Kim, Kwangmeyung |
| 2021-05 | Endothelial angiogenic activity and adipose angiogenesis is controlled by extracellular matrix protein TGFBI | Lee, Seul Gi; Kim, Jin Soo; Kim, Ha-Jeong; Schlaepfer, David D.; Kim, In-San; Nam, Ju-Ock |
